Notable Movers: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Bayer AG (ADR) (OTCMKTS:BAYRY)

Pfizer Inc (NYSE:PFE) Insider Geno J. Germano unloaded 30,000 shares of the stock on the open market in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $29.68, for a total value of $890,400.00. Following the transaction, the insider now directly owns 263,495 shares of the company’s stock, valued at approximately $7,820,532. Pfizer Inc. (NYSE:PFE) stock performance was 0.17% in last session and finished the day at $29.64. Traded volume was 23.39million shares in the last session and the average volume of the stock remained 30.43million shares. The beta of the stock remained 0.67. Pfizer Inc. (NYSE:PFE) insider ownership is 0.10%.

Drugmaker Merck & Co., Inc. (NYSE:MRK) has a tablet for house dust mite allergies in final patient testing that could hit the market in two or three years, and it’s considering other therapies. France’s Stallergenes SA is testing a tablet for birch tree allergies and, with partner Shionogi & Co. Ltd. in Japan, tablets for allergies to dust mites and Japanese cedar pollen. Britain’s Circassia Ltd. has a cat allergy treatment in final testing and six others in earlier testing. Merck & Co., Inc. (NYSE:MRK) rose 0.03 percent to $57.93 Wednesday on volume of 6.88million shares. The intra-day range of the stock was $57.51 to $58.01. Merck & Co., Inc. (NYSE:MRK) has a market capitalization of $169.71billion.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), the discoverer of the BELVIQ® drug, today announced initiating the dosage of a pivotal Phase 1b clinical trial of its novel APD334 drug. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’s stock on June 03, 2014 reported a increase of 0.67% to the closing price of $6.05. Its fifty two weeks range is $4.05 -$9.05. The total market capitalization recorded $1.33billion. The overall volume in the last trading session was 2.67million shares. In its share capital, ARNA has 319.64million outstanding shares.

Earlier this month, Bayer AG (ADR) (OTCMKTS:BAYRY) of Germany agreed to buy Merck’s consumer care business for $14.2 billion. On Wednesday, shares of Bayer AG (ADR) (OTCMKTS:BAYRY) dropped -0.13% to close the day at $143.57.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone